期刊文献+

低分子量灰树花多糖的分离、纯化和抗肿瘤活性 被引量:16

Separation, Purification and Antitumor Activities of Low Molecular Weight Polysaccharide from Grifola frondosa
下载PDF
导出
摘要 目的:从灰树花菌丝体中分离纯化低分子量多糖并进行结构鉴定和抗肿瘤活性检测。方法:采用大孔吸附树脂和离子交换纤维素进行分离,SephadexG200柱层析纯化,HPGFC测定分子量,紫外光谱、红外光谱、薄层色谱和高效液相色谱和气相色谱等进行纯度和结构鉴定。用荷瘤小鼠检测抗肿瘤活性。结果:得到大、小两种多糖组分,其中低分子量多糖为白色粉末状,分子量约为2600,单糖组成为D葡萄糖,含α1,3,α1,6,α1,4糖苷键,对S180肉瘤、EAC腹水瘤、Heps实体瘤都有明显抑制作用。结论:分离得到一种灰树花菌丝体多糖,为低分子量的α葡聚糖,初步药效试验表明其具有抗肿瘤作用。 AIM: To separate and purify low molecular weight polysaccharide from Grifola frondosa. METHODS: The polysaccharide was decolored by macroporous resin and separated by Sephadex G200, and examined with UV, IR, TLC, HPLC and GC. RESULTS: A colorless polysaccharide (GFP2) was obtained. MW of GFP2 was only 2600. TLC analysis of the acid hydrolyzed product and GC analysis of the acetylized product showed that the polysaccharide was composed of D-glucose. IR spectrum revealed it contained α-glucosidie bonds. Glucose was linked by α-1, 3, α-1, 6, α-1, 4-glucosidic bonds in GFP2. GFP2 showed some antitumor activity to S180, EAC and HEPS. CONCLUSION: A kind of low MW α-gluean (GFP2) was obtained from Grifola frondosa mycelium and showed antitumor activity.
出处 《中国天然药物》 SCIE CAS CSCD 2006年第1期77-80,共4页
基金 教育部高等学校科技创新工程重大项目(No.130105)资助课题~~
关键词 灰树花菌丝体 多糖 分离纯化 理化性质 分子量 抗肿瘤 Grifola frondosa mycelium, Polysaccharide, Purification, Characterization, Low molecular weight, Antitumor
  • 相关文献

参考文献10

  • 1[1]Lee BC,Bae JT,Pyo HB,et al.Biological activities of the polysaccharides produced from submerged culture of edible Basidiomycete Grifola frondosa[J].Enzyme Microb Technol,2003,32 (5):574-581.
  • 2[2]Kurushima H,Kodama N,Nanba H.Actives of polysaccharides obtained from Grifola frondosa on insulin-dependent diabetes mellitus induced by streptozotocin in mice[J].Mycoscience,2000,41 (5):473-480.
  • 3[3]Mau JL,Lin HC,Song SF.Antioxidant properties of several specialty mushrooms[J].Food Res Inter,2001,35 (6):519-526.
  • 4舒砚君,孙汉英,董凌莉,徐慧珍,路武,刘文励.川芎嗪对免疫介导再生障碍性贫血小鼠骨髓细胞CD_(34)抗原表达的影响[J].中国中西医结合杂志,1998,18(2):107-108. 被引量:50
  • 5[5]Inoue A,Kodama N,Nanba H.Effect of maitake (Grifola frondosa) D-fraction on the control of T lymph node Th-1/Th-2 proportion[J].Bio Pharm Bull,2002,25 (4):536-540.
  • 6[6]Kodama N,Yamada M,Nanba H.Addition of Maitake D-fraction reduces the effective dosage of vancamycin for the treatment of Listeria-infected mice[J].Jap J Pharm,2001,87 (4):327-332.
  • 7边杉,叶波平,奚涛,韩兆青,吴梧桐.灰树花多糖的研究进展[J].药物生物技术,2004,11(1):60-63. 被引量:51
  • 8[9]徐叔云(Xu SY),卞如濂 (Bian RL),陈修 (Chen X).药理实验方法[M].第3版.北京:人民卫生出版社,2002,1758-1759.
  • 9[10]吴梧桐(Wu WT).生物制药工艺学[M].北京:中国医药科技出版社,1995.120-125.
  • 10王健,龚兴国.多糖的抗肿瘤及免疫调节研究进展[J].中国生化药物杂志,2001,22(1):52-54. 被引量:162

二级参考文献43

  • 1田庚元,冯宇澄.多糖类免疫调节剂的研究和应用[J].化学进展,1994,6(2):114-124. 被引量:76
  • 2余上才,章育正.牛膝多糖抗肿瘤作用及免疫机制实验研究[J].中华肿瘤杂志,1995,17(4):275-278. 被引量:75
  • 3刘卫军,顾振纶,周文轩,郭次仪.植物多糖抗肿瘤活性研究进展[J].中国野生植物资源,1997,16(1):1-4. 被引量:39
  • 4张建忠,国外医学.输血及血液学分册,1995年,18卷,4期,224页
  • 5浦权,骨髓活检病理学,1993年,59页
  • 6谢仁敷,中西医结合杂志,1988年,8卷,10期,616页
  • 7Ohno N, Adachi Y, Suzuki L, et al. Characterization of the antitumor glucan obtained from liquid-cultured Grifola frondosa[J]. Chem Pharm Bull, 1986,34:1709.
  • 8Mayell M, Maitake extracts and their therapeutic potential [J]. Altern Med Rev, 2001,6: 6.
  • 9Ohno N, Adachi Y, Suzuki I, et al. Antitumor activity of a β-1,3-glucan obtained from liquid-cultured mycelium of Grifola frondosa[J]. J Pharmacobiodyn, 1986,9: 861.3
  • 10.

共引文献257

同被引文献190

引证文献16

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部